Deacetylforskolin ameliorates bleomycin-induced pulmonary fibrosis by suppressing inflammation and TGF-β1-induced epithelial–mesenchymal transition
Natural Products and Bioprospecting · 2026-12 · 16 (1)
DOI: 10.1007/s13659-026-00593-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Natural Products and Bioprospecting, online erschienen am 13.04.2026. Verfasst von Yan Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, Kunming Medica…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Yunnan Provincial Science and Technology Department.
Abstract (Originalsprache)
Pulmonary fibrosis (PF) is a chronic, progressive and irreversible inflammatory disease with limited therapeutic methods in clinic. Deacetylforskolin (DFSK), derived from the plant Coleus forskohlii , is a potent adenylyl cyclase activator with potential anti-inflammatory activity. Herein, we attempted to investigate the therapeutic potential and mechanisms of DFSK against PF in bleomycin (BLM)-induced mouse models and TGF-β1-induced A549 cells. Our results showed that DFSK treatment alleviated lung injury and reduced inflammatory cytokines in a mouse model of BLM-induced acute lung inflammation, an early stage of PF. In a BLM-induced PF mouse model, DFSK attenuated pathological lung injury and collagen deposition, decreased pro-inflammatory cytokines (TNF-α, IL-1β) and profibrotic mediators (TGF-β1, CTGF, hydroxyproline). Upregulation of the epithelial marker E-cadherin and downregulation of the mesenchymal marker α-SMA were observed following DFSK treatment. Furthermore, DFSK significantly restored the pulmonary function of PF mice with decreased Te, f, Penh and increased RT, TV. Mechanistically, DFSK suppressed the phosphorylation of JNK and p38 MAPK, and inhibited TGF-β1-induced epithelial–mesenchymal transition (EMT) in A549 cells. Collectively, our findings demonstrate that DFSK is an effective therapeutic agent against PF by suppressing inflammation and EMT. Graphical Abstract
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, Kunming Medical University, Kunming, 650500, China.
- The People's Hospital of Dechang County, Liangshan Yi Autonomous Prefecture, Sichuan, 615500, China.
- School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, Kunming Medical University, Kunming, 650500, China. shangwenbin@kmmu.edu.cn.
- School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, Kunming Medical University, Kunming, 650500, China. ywmbessie@yeah.net.
- School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, Kunming Medical University, Kunming, 650500, China. zhangxuan@kmmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Yunnan Provincial Science and Technology Department
Zitieren
APA
Zhong, Y., Xiao, C., Liang, Y., Wang, P., Long, Y., Li, S., Song, N., Shang, W., Yang, W., & Zhang, X. (2026). Deacetylforskolin ameliorates bleomycin-induced pulmonary fibrosis by suppressing inflammation and TGF-β1-induced epithelial–mesenchymal transition. Natural Products and Bioprospecting, 16(1). https://doi.org/10.1007/s13659-026-00593-4
Vancouver
Zhong Y, Xiao C, Liang Y, Wang P, Long Y, Li S, et al. Deacetylforskolin ameliorates bleomycin-induced pulmonary fibrosis by suppressing inflammation and TGF-β1-induced epithelial–mesenchymal transition. Natural Products and Bioprospecting. 2026;16(1). doi:10.1007/s13659-026-00593-4
BibTeX
@article{Zhong2026,
author = {Zhong, Yan and Xiao, Chuang and Liang, Yaping and Wang, Peng and Long, Yun and Li, Shuyi and Song, Na and Shang, Wenbin and Yang, Weimin and Zhang, Xuan},
title = {Deacetylforskolin ameliorates bleomycin-induced pulmonary fibrosis by suppressing inflammation and TGF-β1-induced epithelial–mesenchymal transition},
journal = {Natural Products and Bioprospecting},
year = {2026},
volume = {16},
number = {1},
doi = {10.1007/s13659-026-00593-4}
}
EUVIMED